Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-Sponsored,Double Blind,Placebo-controlled,Randomised,Multi-centre Study to Assess the Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke

NCT01364220 is registered in ClinicalTrials.gov with Severance Hospital as lead sponsor.

NCT NCT01364220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01364220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-Sponsored,Double Blind,Placebo-controlled,Randomised,Multi-centre Study to Assess the Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke
Lead sponsor
Severance Hospital
Phase
Phase 3
Overall status
Terminated
Start date
August 31, 2010
Completion date
April 30, 2013
Enrollment
318 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

stroke